Nordion, a Sotera Health company, is a leading global provider of mission-critical radioisotopes and sterilization technologies used for the prevention, diagnosis, and treatment of disease and for industrial applications. For over 70 years, Nordion has been committed to enhancing the health and well-being of people around the world by supplying Cobalt-60, a key isotope for gamma sterilization and medical device sterilization, and medical isotopes used in nuclear medicine. Their expertise supports healthcare providers, pharmaceutical companies, and research institutions in delivering safe and effective products and treatments.
Serves as the main hub for isotope processing (notably Cobalt-60), research and development, global operations management, and corporate functions. It is a critical site for Cobalt-60 production and supply.
Advanced facilities for handling radioactive materials, including hot cells, specialized processing equipment, and high-security measures compliant with nuclear industry standards.
A culture focused on safety, precision, innovation, and reliability, driven by the critical nature of its products. Strong emphasis on scientific expertise, operational excellence, and stringent quality control.
A globally significant site for the production and supply of Cobalt-60, essential for medical device sterilization, cancer treatment, and various industrial applications. Plays a vital role in the global healthcare supply chain.
Nordion supports global healthcare and industrial markets through the worldwide supply of Cobalt-60 from its Ottawa facility and medical isotopes from its Vancouver operations. They maintain an extensive global distribution network and customer base, serving sterilization facilities, hospitals, clinics, and research institutions in over 40 countries. Their global functions include international sales, dedicated customer support, specialized logistics for the safe transport of radioactive materials, and ensuring regulatory compliance across diverse international jurisdictions.
447 March Road
Ottawa
Ontario
Canada
Address: Operates a cyclotron facility, with activities often in partnership or proximity to TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3
Serves as a key production and supply hub for critical short-lived medical isotopes for the North American market, particularly supporting healthcare providers in Western Canada and the US Pacific Northwest.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Nordion' leadership includes:
Nordion has been backed by several prominent investors over the years, including:
Public information regarding executive hires or exits specifically at the Nordion subsidiary leadership level within the strict last 12 months (approx. mid-2023 to mid-2024) is limited. Most high-level executive news would be announced at the Sotera Health parent company level. No prominent Nordion-specific top-tier (President, direct VP reports) changes were found in public records for this period.
Discover the tools Nordion uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Nordion, as part of Sotera Health, likely follows common corporate email structuring. Based on analysis of common patterns for the nordion.com domain, the predominant email format appears to be the first initial of the first name followed by the full last name.
f[last]@nordion.com
Format
kbrooks@nordion.com
Example
85%
Success rate
Sotera Health Investor Relations • May 1, 2024
Sotera Health announced its Q1 2024 financial results, where the performance of its Nordion segment was noted. Nordion's supply of Cobalt-60 and medical isotopes continues to be a significant contributor to Sotera Health's mission-critical services in the healthcare industry, with stable demand reported for Cobalt-60....more
Sotera Health Investor Relations • February 28, 2024
In its full-year 2023 earnings report, Sotera Health emphasized the consistent demand for Nordion's products. The company highlighted ongoing investments in the Cobalt-60 supply chain and underscored Nordion's strategic importance for long-term growth in medical device sterilization and nuclear medicine sectors....more
World Nuclear News • October 10, 2023
Nordion signed a Memorandum of Understanding (MOU) with Kinectrics to jointly develop and deploy innovative isotope production technology. This collaboration aims to utilize Kinectrics' licensed Class II nuclear facility to enhance the supply of critical medical isotopes for the global market....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Nordion, are just a search away.